Weijun Liu

Dr. Weijun Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2023 in Fitoterapia
Verified
Journal Article
Closed access
WLWeijun Liu
Weijun Liu
ZTZhengwei Tu
Zhengwei Tu
JLJinjin Liu
Jinjin Liu
TWTeng Wu
Teng Wu
DLDonghua Li
Donghua Li
YCYunfeng Cui
Yunfeng Cui

10 November 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
WLWeijun Liu
Weijun Liu
JLJinjin Liu
Jinjin Liu
TWTeng Wu
Teng Wu
HSHugh Smyth
Hugh Smyth
YCYunfeng Cui
Yunfeng Cui

8 April 2021 in Research Square
Verified
Preprint
Open access
PDF file
WLWeijun Liu
Weijun Liu
JLJinjin Liu
Jinjin Liu
TWTeng Wu
Teng Wu
DLDonghua Li
Donghua Li
YCYunfeng Cui
Yunfeng Cui
Background: Cholelithiasis, known as gallstone, was a common and frequently occurring disease worldwide. Mucus was a viscoelastic protective layer lining the surface of mucosa and synthesized by specialized epithelial cells. Yinchenhao decoction was a classic prescription, first documented in Treatise on Febrile Disease. It had a definite and significant therapeutic effect on cholelithiasis, used as a complement to surgery. Our study aimed to investigate the pathological mechanism of cholelithiasis and the therapeutic mechanism of yinchenhao decoction via mucin from gallbladder-intestine.Methods: The solubility of cholesterol in fasted state simulated intestinal fluid (FaSSIF) without and with mucin was tested. The experiment of supersaturation stability was designed by solvent-shift method. The animal experiment was performed by cholelithiasis model of high cholesterol diet. The stones were observed and the related lipid was tested by automatic biochemical analyzer. The mucin was detected by PCR and western blot. Statistics was analyzed using χ2-tests and t-tests.Results: There was no significant difference in the solubility of cholesterol between FaSSIF without and with mucin. Tss or AUC significantly increased with addition of mucin to FaSSIF (p<0.05). A significant difference was observed in stone rate between the normal group and the model group (p<0.05). Stone rate in the model group showed a significant difference from the yinchenhao decoction group (aspirin group) (p<0.05). The level of related lipid showed a significant increase between the normal group and the model group (p<0.05), while there was a significant decrease between the model group and the yinchenhao decoction group (aspirin group) (p<0.05). A significant increase in the MUC5AC or MUC2 expression was observed between the normal group and the model group (p<0.01). The yinchenhao decoction group (aspirin group) caused a significant decrease in the MUC5AC or MUC2 expression, compared with the model group (p<0.01).Conclusions: In cholelithiasis, the mucin in gallbladder (MUC5AC) highly expressed, shortened cholesterol supersaturation, and promoted cholesterol crystallization; the mucin in small intestine (MUC2) highly expressed, prolonged cholesterol supersaturation, and promoted cholesterol absorption. The yinchenhao decoction inhibited the expression of mucin from gallbladder-intestine for the treatment of cholelithiasis.

5 October 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
WLWeijun Liu
Weijun Liu
Ling WeiLing Wei
Ling Wei
YKYoshikatsu Kanai
Yoshikatsu Kanai
HXHe Xin
He Xin
Bulbus fritillariae and Radix aconiti praeparata are an incompatible herbal pair in the traditional Chinese medicine theory eighteen incompatible medicaments, and they should not be used simultaneously in clinical treatment for safety. This study aimed to investigate the incompatibility mechanism between Bulbus fritillariae and Radix aconiti praeparata based on their interaction with P-glycoprotein (P-gp). The interaction between Bulbus fritillariae and Radix aconiti praeparata during in vitro decocting as well as in vivo absorption was investigated by determining the dry extract yield and by rat single-pass intestinal perfusion (SPIP) model. Inhibition of different species of Bulbus fritillariae on P-gp function was examined using the SPIP model. The mRNA and protein expression of P-gp was determined by PCR and western blotting. The active ingredients of Bulbus fritillariae were predicted and screened for inhibiting P-gp activity by Schrodingers molecular docking and MDR1-MDCK cell transport study, respectively. Mediation of monoester alkaloids in Radix aconiti praeparata by P-gp was predicted and examined using Schrodingers molecular docking and SPIP experiment, respectively. In the results, when Radix aconiti praeparata was combined with Bulbus fritillariae, the toxic ingredient benzoylmesaconine in Radix aconiti praeparata displayed higher intestinal permeability, whereas the toxic ingredients showed no significant difference during the in vitro decoction process. Bulbus fritillariae thunbergii inhibited both the P-gp function and expression; in contrast, Bulbus fritillariae cirrhosae inhibited the function only. Alkaloids including peimine, peimisine, and imperialine were the active ingredients for inhibiting P-gp activity. Benzoylmesaconine in Radix aconiti praeparata was the substrate of P-gp.

4 June 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
WLWeijun Liu
Weijun Liu
HSHugh Smyth
Hugh Smyth
NZNan Zhang
Nan Zhang